TP53 and breast neoplasm: Freed-Pastor et al. demonstrated that the highly expressed sterol biosynthesis-related genes in breast tumors were bound up with TP53 mutations and statins could inhibit the proliferation of TP53 mutations cancer cells (Freed-Pastor et al., 2012).